Table 2 Findings Related to the Medical Characteristics of the Patients
Medical Characteristics | GROUPS | Total | Statistical Analysis* | ||||
|---|---|---|---|---|---|---|---|
Study (n = 60) | Control (n = 60) | ||||||
n | % | n | % | n | % | ||
Diagnosis | |||||||
Over Ca | 26 | 43.3 | 21 | 35.0 | 47 | 39.2 | x 2 = 2.286 p = 0.319 |
Cervical Ca | 13 | 21.7 | 15 | 25.0 | 28 | 23.3 | |
Endometrial Ca | 21 | 35.0 | 24 | 40.0 | 45 | 37.5 | |
Stage | |||||||
Stage I | 19 | 31.6 | 16 | 26.7 | 35 | 29.2 | x 2 = 0.843 p = 0.656 |
Stage II | 28 | 46.7 | 25 | 41.7 | 53 | 44.2 | |
Stage III | 13 | 21.7 | 19 | 31.6 | 32 | 26.6 | |
Operation type | |||||||
TAHBSO | 20 | 33.3 | 24 | 40.0 | 44 | 36.7 | x 2 = 0.217 p = 0.642 |
TAHBSO+PALND | 40 | 76.7 | 36 | 60.0 | 76 | 63.3 | |
Operations history | |||||||
Yes | 23 | 38.3 | 27 | 45.0 | 50 | 41.6 | x 2 = 0.420 p = 0.517 |
No | 37 | 61.7 | 33 | 55.0 | 70 | 58.4 | |
Information about the disease | |||||||
Yes | 29 | 48.3 | 33 | 55.0 | 62 | 51.6 | x 2 = 0.391 p = 0.532 |
No | 31 | 51.7 | 27 | 45.0 | 58 | 48.4 | |
Total | 60 | 50.0 | 60 | 50.0 | 120 | 100.0 | |